» Articles » PMID: 31144467

A Chinese Practice Guideline of the Assisted Reproductive Technology Strategies for Women with Advanced Age

Overview
Date 2019 May 31
PMID 31144467
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

More women postpone childbearing nowadays while female fertility begins to decline with advancing age. Furthermore, with the rolling out of the two-child policy, there is a huge demand for a second child for Chinese aged women. There are various assisted reproductive technology (ART) strategies applied for age-related infertility without solid evidence. On behalf of the Society of Reproductive Medicine, Chinese Medical Association, we would like to develop a Chinese guideline of ART strategies for age-related infertility. This guideline was produced following the recommendations for standard guidelines described in the 2012 WHO Handbook for guideline development. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was also followed. A protocol was formulated and a Guideline Development Group was formed with specialists of reproductive medicine, methodologists from Chinese GRADE working group, and patient representative. Questions regarding the ART strategies for aged infertility were formulated and 8 most important ones were chosen to be structured in PICO format (Population, Intervention, Comparison, Outcomes). Comprehensive search and review of the literature were performed and the quality of the evidence was assessed and rated based on certain criteria and be categorized as high, moderate, low, or very low. Twenty-five recommendations were formulated among members of the Guidelines Development Group (Delphi method) basing on the overall quality of the evidence, in addition to the balance between benefits and harms, values and preferences, and resource implications. The final recommendations were agreed on by consensus during face-to-face meetings. This is the first Chinese practice guideline in reproductive medicine developed following the standard and scientific method.

Citing Articles

Lactate accumulation from HIF-1α-mediated PMN-MDSC glycolysis restricts brain injury after acute hypoxia in neonates.

Zhang X, Peng L, Kuang S, Wang T, Wu W, Zuo S J Neuroinflammation. 2025; 22(1):59.

PMID: 40025545 PMC: 11871681. DOI: 10.1186/s12974-025-03385-8.


Growth hormone improves the pregnancy outcomes in poor ovarian responders undergoing in vitro fertilization: an umbrella review.

Liu Y, Ding F, Yang Y, Ma B J Assist Reprod Genet. 2025; .

PMID: 39862359 DOI: 10.1007/s10815-025-03389-6.


Reflections on appropriately liberalizing ART for groups requiring special attention in China.

Dong X, Sun W, Du P, Xiao Q, Ren H J Assist Reprod Genet. 2024; 41(7):1755-1761.

PMID: 38958870 PMC: 11263302. DOI: 10.1007/s10815-024-03184-9.


Comparison of pregnancy outcomes among patients of different ages who underwent frozen-thawed high-quality single blastocyst transfer.

Chen H, Wu S, Su W, Zhao J, Wu Y BMC Pregnancy Childbirth. 2024; 24(1):276.

PMID: 38622514 PMC: 11017700. DOI: 10.1186/s12884-024-06451-w.


Effects of the Zishen Yutai Pill compared with placebo on pregnancy outcomes among women in a fresh embryo transfer cycle: a subgroup analysis of a randomized controlled trial.

Chen X, Li Y, Zhou J, Wei X, Ning N, Huang Q Front Endocrinol (Lausanne). 2023; 14:1196636.

PMID: 38075073 PMC: 10703301. DOI: 10.3389/fendo.2023.1196636.